The prognostic value of UHRF-1 and p53 in gastric cancer


Babacan N. A. , EĞİLMEZ H. R. , YÜCEL B., Parlak I., Seker M. M. , Kacan T., et al.

SAUDI JOURNAL OF GASTROENTEROLOGY, cilt.22, ss.25-29, 2016 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 22 Konu: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4103/1319-3767.173755
  • Dergi Adı: SAUDI JOURNAL OF GASTROENTEROLOGY
  • Sayfa Sayısı: ss.25-29

Özet

Background/Aims: This study aimed to examine whether UHRF-1 and p53 overexpression is a prognostic marker for gastric cancer. Patients and Methods: Sixty-four patients with gastric cancer (study group) and 23 patients with gastritis (control group) were evaluated. Immunohistochemistry was used to examine expression of UHRF-1 and p53 in gastric cancers and a control group diagnosed with gastritis. Results: The median age was 63 years (18-83 years) in the study group. UHRF-1 was positive in 15 (23%) patients with gastric cancer and fi ve (21.7%) patients with gastritis (P = 0.559). UHRF1 expression level in gastric cancer is more powerful than in gastritis (P = 0.046). Thirty-seven (61%) patients with gastric cancer and only one patient with gastritis were p53 positive (P < 0.001). After a median follow-up of 12 months (1-110), the 2-year overall survival rates were 55% and 30% in negative and positive p53, respectively (P = 0.084). Also, the 2-year overall survival rates were 45% and 53% in negative and positive UHRF-1, respectively (P = 0.132). Conclusion: According to this study, UHRF-1and p53 were not prognostic factors for gastric cancer, whereas they may have a diagnostic value for differantiating between gastric cancer and gastritis.